A novel human protein kinase, designated kpm, was identi®ed and molecularly cloned. The isolated cDNA clone had an open reading frame consisting of 1088 amino acid residues with a putative kinase domain located near the carboxy-terminus. Homology search revealed that kpm belongs to a subfamily of serine/ threonine protein kinases including warts/lats, a Drosophila tumor suppressor. Among these, kpm is most homologous to, but distinct from, recently reported LATS1, a human homolog of Drosophila warts/lats. Northern blot analysis disclosed that kpm is expressed as a 6.0 kb transcript in most of the tissues examined and also as an additional shorter 4.0 kb transcript in testis. Western blotting using polyclonal rabbit anti-kpm antibody detected kpm protein as a band with an apparent M r of 150 kD. Immune complex kinase assay of HAtagged kpm showed that kpm had kinase activity and phosphorylated itself in vitro. Studies with synchronized HeLa cells indicated that kpm protein was expressed relatively constantly throughout the cell cycle and underwent signi®cant phosphorylation at mitotic phase. These results suggest that kpm plays a role in cell cycle progression during mitosis and its deletion or dysfunction might be involved in certain types of human cancers.
Introduction
Evidence has indicated that fundamental cellular functions in eukaryotes are regulated by reversible enzymatic reactions of protein phosphorylation and dephosphorylation (Hunter, 1995) . A number of protein kinases have been identi®ed and shown to be involved in crucial cellular events, such as signal transduction, in response to extracellular stimuli and regulation of cell cycle progression. The structures and functions of these protein kinases are highly conserved throughout species, re¯ecting that they play important roles in the survival of the organisms. Based on this conservation, characterization of protein kinases in lower eukaryotes have provided insights into intracellular signal transduction as well as cell cycle regulation in mammalian cells. The basic framework of cell cycle regulation that depends on cyclins and CDC (CDK) kinases was ®rst established in yeast, and later counterparts of most of the principal regulators of cell cycle have been identi®ed in multicellular organisms (Nurse, 1994; Morgan, 1997) . However, our knowledge is still limited concerning the process of cell and nuclear division, where unde®ned cascades of protein kinase reaction seem to coordinate the complicated series of subcellular events. It is, therefore, important to identify and characterize any of such protein kinases for thorough understanding of the mechanism of cell proliferation and oncogenesis.
Recently, a new subfamily of protein kinases has emerged consisting of dbf2 of budding yeast (Johnston et al., 1990) , orb6 of ®ssion yeast (Verde et al., 1998) , cot-1 of Neurospora crassa (Yarden et al., 1992) , warts/lats of Drosophila melanogaster (Justice et al., 1995; Xu et al., 1995) , ndr of various spices (Millward et al., 1995) , and a few other related kinases. The members of this subfamily have considerable similarities in function as well as in structure of the catalytic domain. Dbf2 plays a role in both initiation of DNA synthesis and late nuclear division. Yeast cells carrying temperature sensitive allele of dbf2 arrest with a uniform large budded`dumb-bell' morphology at the restricted temperature due to cell division failure. Orb6 is required for maintenance of cell polarity during interphase and to promote actin reorganization during morphological transitions. Cot-1 regulates hyphal growth and branching in Neurospora crassa. Drosophila warts/lats has been identi®ed as a tumor suppressor gene by screening for overproliferation mutations in genetic mosaics. Homozygous deletion of this gene in somatic cells causes overproliferation and morphological abnormalities. Thus, protein kinases of this subfamily seem to be involved in cell cycle regulation and cell morphogenesis.
We have been searching for novel protein kinases that are expressed in human hematopoietic progenitor cells and potentially underlying the leukemogenesis. During screening of cDNA of human myeloid cell lines by degenerate PCR, we encountered a fragment of an unknown protein kinase gene, which was the beginning and the focus of the present study. Here, we describe identi®cation and isolation of a novel human protein kinase, kpm, that is highly homologous to Drosophila warts/lats. Comparison with other protein kinases clearly indicates that this kinase belongs to the emerging novel subfamily of protein kinases described above. We examined its expression in various human tissues, detected the protein product by Western blot and carried out in vitro kinase assay. We found that kpm expression is relatively constant throughout the cell cycle but speci®cally phosphorylated during mitosis. Its possible role in cell cycle regulation and oncogenesis is discussed.
Results

Identification and molecular cloning of a novel serine/ threonine kinase
To identify protein kinases expressed in hematopoietic progenitor cells, PCR was performed with degenerate primers using KG-1a cDNA library as a template. Several principal PCR products detected in agarose gel electrophoresis were puri®ed and cloned into pT7BlueT vector for sequencing. The sequence analysis showed that three of 12 cDNA clones examined had an identical sequence containing a putative kinase domain. Homology search of this cDNA fragment indicated that it was highly homologous to warts/lats, a Drosophila tumor suppressor gene with a serine/ threonine kinase domain. We named this molecule kpm (a kinase phosphorylated during mitosis) according to the M phase-speci®c phosphorylation pattern as shown below. Northern blot analysis with KG-1a polyA + RNA, using a fragment of kpm cDNA as a probe, showed expression of 6.0 kb mRNA. In order to obtain full-length cDNA clones of this gene, we screened the KG-1a cDNA library by combination of PCR-based enrichment and colony hybridization. KG1a cDNA library consisting of about 1.6610 5 independent clones was divided into 40 pools and examined for existence of the gene by PCR with a pair of speci®c primers. Three positive pools #3, #20 and #44 were selected and further divided into 40 pools of 10 3 independent clones. Then, colony hybridization was done using a DNA probe that was generated by PCR. Three independent clones, pME-kpm-03, -20 and -44 with inserts of 4.1, 1.6 and 1.7 kb, respectively, were isolated and subjected to sequencing by dye dideoxy terminator with an automated sequencer. Sequence analysis indicated that these clones overlapped each other and presumably derived from a single gene. Therefore, the longest clone pME-kpm-03 (pME-kpm) was analysed in detail.
Nucleotide and amino acid sequences of kpm
The insert of pME-kpm contained an open reading frame consisting of 1088 amino acid residues with a Kozak consensus sequence at the 5'¯anking region (Figure 1 ). Since there were stop codons within 30 bases upstream of the putative initiation codon in this frame, it seemed likely that this clone covers the entire coding region. The consensus kinase catalytic domain is located at the carboxy-terminus of the protein and contains all 11 subdomains of serine/threonine kinases (Hanks and Quinn, 1991) . Homology search revealed that kpm belongs to a subfamily of protein kinases comprised of dbf2 of budding yeast (Johnston et al., 1990) , orb6 of ®ssion yeast (Verde et al., 1998) , cot-1 of Neurospora crassa (Yarden et al., 1992) , warts/lats of Drosophila (Justice et al., 1995; Xu et al., 1995) , ndr kinase conserved throughout species (Millward et al., 1995) , and some other related protein kinases. During characterization of kpm, human and mouse LATS1, homologs of Drosophila warts/lats, have been reported St John et al., 1998) . It was shown that expression of human LATS1 could suppress tumor formation in mosaic¯ies and made lats mutant cells develop into normal adult structures, indicating that human LATS1 is an authentic homolog of Drosophila warts/lats. Among the members of this subfamily, kpm is most homologous to but distinct from human LATS1. Kpm, human LATS1, and Drosophila warts/lats are highly homologous to each other, particularly in the catalytic domains, but some patchy homologous sequences can be found also in the amino-terminal domains (Figure 2) . The predicted catalytic domain of kpm has 84.6% identical amino acids to human LATS1, 74.4% to Drosophila warts/lats, 51.3% to human ndr, 50.7% to ®ssion yeast orb6, 48.5% to cot-1 of Neurospora crassa, and 37.7% to budding yeast dbf2 (Figure 3 ). The members of this subfamily have a distinctive insertion of about 40 amino acid residues between the VII and VIII kinase subdomains. It is also noted that kpm has signi®cant homology to human myotonic dystrophy kinase (DM kinase) (Mahadevan et al., 1993) in the catalytic domain although DM kinase does not have the insertion and may not be included in the above-mentioned subfamily of protein kinases.
Expression of kpm mRNA in human tissues
Expression of kpm mRNA was examined by Northern blot analysis using Multiple Tissue Northern Blots, Human I and II (Clontech) in which equal 2 mg polyA + RNA of each tissue was applied. As shown in Figure 4 , kpm was expressed in most of the tissues examined as a 6.0 kb transcript. In testis, an additional 4.0 kb transcript was present. Among the tissues examined, heart, skeletal muscle and testis expressed relatively high levels of kpm mRNA, while its expression was low or scarcely detectable in brain, liver, kidney, and thymus. Several human cell lines examined, including HeLa, expressed kpm mRNA, which was in accordance with the broad distribution in human tissues (data not shown).
Detection and analysis of kpm protein
In order to detect the kpm protein, we immunized rabbits with recombinant amino-terminal polypeptide of kpm protein and generated polyclonal anti-kpm Ab. Then the cell lysates of HEK293T transfected with pME-kpm, KG-1a, and HeLa were subjected to SDS ± PAGE with 7.5% acrylamide gel and Western blot analysis using anti-kpm Ab. As shown in Figure 5 , a band with an apparent M r of 150 kD was detected by anti-kpm Ab but not by control rabbit IgG in each of these samples although the background levels were relatively high. These results indicate that endogenous kpm is expressed as a 150 kD protein and pME-kpm seems to encode a protein of the same size as the endogenous one.
Immune complex kinase assay
Immune complex kinase assay was performed to examine whether kpm protein had protein kinase activity. HA-tagged kpm protein as well as HA-tagged kpmK697A mutant protein with no kinase activity was expressed in HEK293T cells and immunoprecipitated by anti-HA mAb. The immune complexes bound to sepharose beads were incubated with [g- Figure 6 , wild type kpm protein phosphorylated itself (autophosphorylation), while the kinase-null mutant kpmK697A protein did not. This was not due to poor expression of the latter, which was con®rmed by Western blotting of the immunoprecipitates with anti-HA mAb (Figure 6, bottom) . As to the exogenous substrates examined, histon HI was considerably, and the other two substrates were weakly, phosphorylated but to the same levels by both wild type and the K697A mutant (data not shown). Thus, it seemed likely that these substrates were not phosphorylated by kpm but by some other factors co-immunoprecipitated with kpm.
Cell cycle dependent phosphorylation of kpm
Dbf2 of budding yeast has been reported to be expressed at G 1 or late G 2 /M phase and involved in cell cycle progression (Johnston et al., 1990) . Furthermore, LATS1, a human homolog of Drosophila warts/lats, has recently been reported to be phosphorylated in a cell cycle-dependent manner . It was implicated that kpm might also undergo cell cycle-dependent modi®cation, since we had experienced that kpm often migrated as a doublet through SDS ± PAGE gel. Therefore, we next examined changes in expression of kpm during cell cycle progression. HeLa cells synchronized at the G 1 / S boundary by the double thymidine method were released and harvested at various time points for immunoblotting by anti-kpm Ab. As shown in Figure  7 , total expression levels of kpm protein were relatively constant throughout the cell cycle. It was noted that a slower mobility band of kpm was observed at 10 h when the majority of the cells were in mitosis. This migration shift of the kpm band at M phase was clearly visualized by the sequential treatment of HeLa cells with aphidicolin and nocodazole that gave more stringent synchronization at G 2 and M phase (Figure 7b ). To determine whether this slower migration was caused by phosphorylation, we carried out phosphatase treatment of kpm protein immunoprecipitated from M phase synchronized HeLa cells (Figure 7c ). Treatment with phasphatase resulted in slightly faster migration of kpm (lane 2) than non-treated (lane 1) and addition of phosphatase inhibitors completely reversed this change (lane 3). These results indicate that kpm is phosphorylated during mitosis.
Effects of overexpression of kpm on cell cycle progression
In order to know the physiological function of kpm, we examined the eects of overexpression of kpm on cell cycle progression. HEK293T cells and HeLa were cotransfected with pEGFP-C3, a GFP expression vector, and either pME18S (mock), pME-kpm, or pME-kpmK697A. After 2 days of culture, cells were harvested, ®xed with 2% formaldehyde, treated with 1 mg/ml ribonuclease A and stained with propidium iodide for cell cycle analysis. GFP + cells were gated and their DNA content was analysed on histograms. These data were also analysed using ModFit LT software (Becton-Dickinson). Dot plots and histograms of a representative experiment with HEK293T cells are shown in Figure 8 . There was a tendency that slightly more cells were in S+G 2 /M phase in transfection of Figure 3 Sequence comparison of kpm with homologous protein kinases. The predicted amino acid sequences of kpm, human LATS1, Drosophila warts/lats, human ndr, orb6, cot-1, DM kinase, and dbf2 were compared using Genetyx-Mac. The position of the catalytic domain is shown in black, and the per cent amino acid identity with this region of kpm is shown in white Figure 4 Expression of kpm mRNA in various human tissues. The membranes of human Multi Tissue Blot I and II (Clontech) on which 2 mg polyA + RNA of each human tissue was applied were hybridized with the radiolabeled probe of kpm cDNA. Then the membranes were washed under the stringent conditions and subjected to autoradiography. The size marker (kb) is indicated Figure 5 Western blot analysis of kpm protein. Cell lysates of HEK293T cells transfected with pME-kpm, KG-1a cells, and HeLa cells were separated by SDS ± PAGE with 7.5% acrylamide gel and transferred to PVDF membrane. The membrane was blotted by polyclonal rabbit anti-kpm Ab and visualized using ECL detection system. The arrow indicates speci®c bands that are detected by the anti-kpm Ab but not by control rabbit IgG Oncogene A novel protein kinase phosphorylated during mitosis T Hori et al kpm as well as kpmK697A compared to mock transfection but no signi®cant dierence was observed between wild type kpm and the kinase-null kpm. We could not specify which cell cycle phase actually increased in this assay system.
Discussion
In the present study, we describe identi®cation and cDNA cloning of a novel human protein kinase, kpm, that is homologous to warts/lats, a Drosophila tumor suppressor gene. Kpm apparently belongs to a novel emerging subfamily of protein kinases that includes dbf2 as well as its close homolog dbf20 (Toyn et al., 1991) of budding yeast, orb6 of ®ssion yeast, cot-1 of Neurospora crassa, warts/lats, ndr kinase conserved throughout species, and a few other related kinases. These kinases have consensus amino acid sequences of serine/threonine kinases and show signi®cant homology especially at the catalytic domain to each other. In particular, they have a unique insert of about 40 amino acid residues between VII and VIII subdomains, which distinguishes them from other somewhat homologous kinases such as DM kinase, rho kinase and cyclic AMP-dependent kinase. Accumulating evidence has suggested that the members of this subfamily have similar functions as well. Dbf2 is a cell cycle-regulated kinase and required for progression through anaphase (Johnston et al., 1990) . Orb6 is required for maintenance of cell polarity during interphase and to promote actin reorganization during morphological transition (Verde et al., 1998) . Cot-1 regulates hyphal growth and branching in Neurospora crassa cells (Yarden et al., 1992) . Warts/lats has been identi®ed as a tumor suppressor in Drosophila and thought to be involved in cell cycle progression and cell morphogenesis (Justice et al., 1995; Xu et al., 1995) . The function of ndr kinases has not been clari®ed yet but shown to be localized in nucleus and regulated by Ca 2+ /S100B, whose overexpression is often observed in melanoma cells (Millward et al., 1998) . Thus, the kinases of this subfamily seem to be in common related to cell cycle regulation and cell morphology.
Recent reports on human and mouse LATS1, homologs of Drosophila warts/lats have shown that LATS1 functionally complement warts/lats mutation in Drosophila, indicating that LATS1 is an authentic homolog of warts/lats . Although kpm is a novel protein kinase distinct from LATS1, these two molecules are highly homologous to each other and, accordingly, kpm is likely to have similar functions to LATS1. It is to be determined whether kpm is another homolog of Drosophila warts/lats. With regard to this point, the dierence in distribution patterns of these two molecules seems to be of particular importance. Northern blot analysis with multiple human tissue polyA + RNA showed that kpm is expressed in many human tissues as LATS1 but appears to have relative preference for certain organs. For example, kpm is scarcely expressed in brain, liver, and kidney where LATS1 is expressed at considerable levels (Tao et al., 1998). As to Figure 6 Autophosphorylation of kpm protein. Immunoprecipitation was done by anti-HA mAb (12CA5) from HEK293T cells transfected with pME-kpm-HA or pME-kpmK697A-HA. The immune complexes bound to sepharose beads were incubated for 10 min at 308C in kinase reaction buer containing 10 mCi [g- their biological roles, one possibility is that kpm and LATS1 are involved in the same cellular events but in a dierent or reverse fashion, as has been reported in the members of the bcl-2 family. Another and more likely possibility is that they are mutually complementary and either of them plays a predominant role depending on types of tissues. If this is the case, it is interesting that LATS1 knockout mice reportedly develop soft tissue sarcomas and ovarian tumors, corresponding to high levels of its expression in these tissues. On the analogy of LATS1, homozygous deletion of kpm may cause tumors in those tissues where kpm is highly expressed.
Although Drosophila warts/lats, human, and mouse LATS1 have putative serine/threonine kinase domains, none of these so far have been demonstrated to possess kinase activity in vitro. We demonstrated that kpm is a functionally competent protein kinase by immune complex kinase assay in which wild type kpm but not the kinase-null mutant phosphorylated itself. The substrate speci®city of kpm seems to be rather restricted because it did not speci®cally phosphorylate any of the exogenous substrates of casein, histon H1, or MBP. As to cell cycle regulation, we showed that kpm is phosphorylated in cell cycle-dependent manner and more speci®cally during mitosis. It is to be determined whether this phosphorylation is autophosphorylation or not. Human LATS1 has also been reported to be phosphorylated at late prophase to metaphase and modulate CDC2/cyclin A complex kinase activity. During preparation of this study, another paper on human warts (LATS1) has been published, in which the authors have con®rmed the cell cycle-dependent phosphorylation of LATS1 and showed that it is complexed with CDC2 in early mitosis (Nishiyama et al., 1999) . They claimed that CDC2/cyclin B appeared to be responsible for the phosphorylation of LATS1. They showed that GST-h-warts/LATS1 (amino acid 395 ± 700) fusion protein (GST-WN) was phosphorylated by mitotic lysates and this phosphorylation was signi®-cantly decreased by depleting CDC2 from the lysate. However, if LATS1 has autophosphorylation activity as kpm, it is possible that the GST-WN was phosphorylated by endogenous LATS1 that was bound to CDC2 and depleted together with CDC2. Thus, further studies are required to clarify the molecular mechanism of phosphorylation of LATS1 as well as kpm.
The physiological function of kpm is unknown. With its homology to other related protein kinases that are involved in cell cycle regulation and cell morphology, kpm is likely to have similar functions. Based on this presumption, we examined the eects of overexpression of kpm on cell cycle progression in HEK293T cells and HeLa cells. To overcome the low eciency of simple transient transfection, we cotransfect these cells with the kpm vectors and a GFP expression vector, and analysed the DNA content in the GFP + cell population that was supposed to express also kpm. We repeated this type of experiment several times and found that overexpression of kpm as well as kpmK697A resulted in a slight increase in percentage of cells in S+G 2 /M (Figure 8 ). There was no signi®cant dierence between wild type kpm and kinase-null kpm, suggesting that the long amino terminal domain rather than the kinase domain of kpm might be important for cell cycle regulation. However, the changes we observed were limited and we could not specify the cell cycle phase that actually increased in this assay system. It is possible that the eects of kpm overexertion might be masked or neutralized by preexisting redundancy or compensatory mechanisms in the cell.
Human cancers are thought to be caused by a series of genetic mutations and the genes involving such processes can vary extensively depending on the tissue and cell type of the origin. Therefore, it is important to ®nd and characterize as many molecules as possible that potentially underlie the abnormal cell growth for better understanding of the diverse mechanisms of human oncogenesis. In this context, identi®cation of warts/lats as a tumor suppressor in Drosophila has opened a new arena of tumor cell biology. Since development of ovarian as well as soft tissue tumors in LATS1 knockout mice strongly suggests that LATS1 functions as a tumor suppressor in mouse and presumably in humans, relationship between LATS1 inactivation and human cancers will be one of the focuses of the future studies. With high homology to LATS1, kpm is most likely to participate in regulation of cell cycle and cell morphology. Molecular analysis of kpm-mediated subcellular events and cytogenetic survey of kpm mutations in cancer cells may contribute to elucidating some aspects of human oncogenesis.
Materials and methods
Degenerate PCR
Poly A + RNA was isolated from KG-1a, a human immature myeloid cell line (Koeer et al., 1980) (obtained from American Type Culture Collection) by Poly(A)Pure, a mRNA puri®cation kit (Ambion, Inc., Austin, TX, USA). A cDNA library consisting of 4.3610 6 independent clones was made from 5 mg of KG-1a polyA + RNA in pME18S, a mammalian expression vector as described (Imura et al., 1996) . Using this cDNA library as a template, PCR was done with original sets of degenerate primers: forward primers 5'-GAYATHAARCCIKAIAA-3' and the reverse primers 5'-CCIARI(GA/CT)CCACCARTC-3' for the common amino acid sequences, DIKP(E/D)N in the VIb subdomain and Figure 8 Eects of overexpression of kpm on cell cycle progression. HEK293T cells were transfected with pME18S (mock), pME-kpm, or pME-kpmK697A together with a GFP expression vector pEGFP-C3. After 2 days, cells were ®xed and stained with propidium iodide for cell cycle analysis. GFP+ cells were gated on the dot plots (top) and the DNA contents in these populations were analysed (bottom). The percentages of S+G 2 /M phase cells are indicated Oncogene A novel protein kinase phosphorylated during mitosis T Hori et al DWWSLG in the IX subdomain of serine/threonine kinases, respectively (Hanks and Quinn, 1991) . The reaction was carried out on Takara SJ2000 thermal cycler (Takara Biomedicals, Kusatsu, Japan) with a cycle program of 1 min at 948C, 1 min at 458C, and 1 min at 728C, 30 cycles. PCR products were fractionated by agarose gel electrophoresis and representative DNA bands were incised. DNA was puri®ed from each piece of gel, ligated with pT7BlueT vector (Novagen, Inc., Madison, WI, USA) and expanded in transformed E. coli. Twelve plasmid clones were randomly selected and sequenced by dye dideoxy terminator using a genetic analyzer Prism310 (Perkin-Elmer Biosystems, Foster City, CA, USA). The sequences were subjected to homology search using a program of Genetyx-Mac/DB (Software Development Co., Ltd., Tokyo, Japan) for GenBank database.
Isolation of the full-length cDNA clones
To obtain full-length cDNA clones of an identi®ed gene, colony hybridization was done after enrichment through PCR-based screening of pooled plasmid clones as follows. An aliquot of KG-1a cDNA library consisting of about 1.6610 5 independent clones was divided into 40 pools and examined for existence of the cDNA by PCR with a pair of speci®c primers located within the identi®ed fragment. Three positive pools were selected, transformed into E. coli and further divided into 40 pools of 10 3 independent clones. Then colony hybridization was carried out with the positive pools using the radiolabeled PCR product as a probe. The whole insert and restriction enzyme-digested fragments of the isolated clones were recloned into pBluescriptIIKS(7) for sequencing on both strands.
Construction of expression vectors
The 3' end fragment of kpm cDNA was ampli®ed by PCR with a forward primer (GCTGACTTTGGCCATTGAGAG-TGTC) and a SpeI-site-tagged reverse primer (CGGAC-TAGTCACGTACACAGGCTGGGAGCCTTCAGTC). The PCR product was cut with BglII and SpeI, and inserted into pME-C3HA that contains three repeats of HA epitope sequences at the 3' end of the multicloning site adjacent to the SpeI site (T Hori, unpublished results) to generate pMEkpm-HA. A kinase-null mutant of kpm was constructed from pME-kpm-HA by oligonucleotide-directed mutagensis (Vallejo et al., 1995) . The region containing the mutation was ampli®ed by the overlap extension method using Advantage-HF PCR Kit (Clontech, Palo Alto, CA, USA), and the mutagenic forward primer (TGTACGCCAATGGCGACCC-TAAGGAA) in which Lys-697 was replaced by alanine and its antisense primer. The PCR product was cut with HincII and BglII for insertion. The kinase-null kpm expression vector pME-kpmK697A-HA was made by replacing the HincII/BglII fragment with the ampli®ed mutant DNA. The sequence of the ampli®ed region was con®rmed by direct DNA sequencing.
Northern blot analysis
Northern blot analysis was done with Multiple Tissue Northern Blots, Human I and II (Clontech) using a 520 bp PstI/BglII fragment of kpm cDNA as a probe. Hybridization with the radiolabeled probe was done according to the supplier's instruction. The membranes were washed under the high stringent conditions and subjected to autoradiography.
Generation of polyclonal anti-kpm antibody
A 5' end fragment of kpm cDNA corresponding to the amino-terminal 1 ± 323 amino acid residues was ampli®ed by PCR using BamHI-and SalI-site-tagged primers, cut with these restriction enzymes, and inserted into pQE32, a bacterial expression vector with a hexahistidine tag sequence (Qiagen, Hilden, Germany). The amino-terminal part of kpm protein was expressed in E. coli SG130009, induced by 1 mM IPTG for the last 4 h before the harvest, and puri®ed from the cell lysates by nickel nitrilotriacetic acid (Ni-NTA) agarose columns (Qiagen). The puri®ed protein was used to immunize rabbits. IgG fraction of the rabbit anti-kpm serum was puri®ed and used for Western blotting and immunoprecipitation.
Western blot analysis
HEK293T cells were transfected with pME-kpm by the calcium phosphate method and harvested after 2 days of culture. The cell lysates of the transfected HEK293T cells as well as those of KG-1a and HeLa were subjected to SDS ± PAGE with 7.5% acrylamide gel. Then the samples were transferred to Immobilon-P PVDF membranes (Millipore, Bedford, MA, USA), incubated sequentially with polyclonal rabbit anti-kpm Ab and peroxidase-conjugated sheep antirabbit Ig (Amersham Pharmacia Biotech, Uppsala, Sweden). Kpm proteins were visualized using ECL detection kit (Amersham Pharmacia Biotech).
Immune complex kinase assay
HEK293T cells transfected with pME-kpm-HA or pMEkpmK697A-HA were harvested, washed with PBS, and lyzed in lysis buer (0.5% Nonidet P-40, 150 mM NaCl, 10 mM Tris-HCl, pH 7.5, 1 mM EDTA, 2 mg/ml aprotinin, 2 mg/ml leupeptin and 2 mg/ml pepstatin A). After centrifugation at 15 000 r.p.m. for 20 min, the supernatants were ®rst precleared by incubation with protein G sepharose FF (Amersham Pharmacia Biotech) for 1 h. Then the cell lysates were incubated with 2 mg/ml anti-HA mAb (12CA5) (Boehringer Mannheim, Mannheim, Germany) and protein G sepharose FF for 4 h. Sepharose beads were washed with the lysis buer ®ve times and once with kinase reaction buer (10 mM MgCl 2 , 3 mM MnCl 2 , 10 mM Tris-HCl, pH 7.2). In vitro kinase reaction was carried out for 10 min at 308C in kinase reaction buer containing 10 mCi [g-32 P]ATP (Amersham Pharmacia Biotech) in the absence or presence of substrates such as casein, histon H1, and myelin basic protein (MBP). Samples were mixed with 26SDS sample buer, boiled and analysed by SDS ± PAGE with 7.5 or 12% acrylamide gel. Phosphorylated proteins were detected by autoradiography.
Cell cycle synchronization of HeLa cells
HeLa cells were ®rst synchronized by double thymidine at G 1 /S boundary as described (Heintz et al., 1983) . Cells were treated with 1 mM thymidine for 24 h, followed by a 8 h release in fresh D-MEM medium (Life Technologies, Rockville, MD, USA) supplemented with 10% fetal calf serum (FCS) and successive retreatment with thymidine for 14 h. Following release, cells were harvested at the indicated time points. To obtain more enriched M-phase cells, nocodazole treatment was carried out according to the method described (Watanabe et al., 1995) . In brief, cells were cultured at 5610 4 /ml in D-MEM medium supplemented with 5% FCS in the presence of 5 mg/ml aphidicolin (Sigma, St. Louis, MO, USA) for 12 h. Then cells were washed three times with fresh D-MEM medium, cultured in complete medium for 6 h, and then treated with 0.1 mg/ml nocodazole (Sigma) for 4 h. Rounded-up cells, mostly in M phase, were collected by gentle pipetting. Cells remaining on the dishes were used as G 2 phase cells. M phase cells were replaced in complete medium and the progression of cell cycle was monitored by propidium iodide staining of ethanol-®xed cells followed bȳ ow cytometric analysis on a FACScan (Becton-Dickinson Immunosystems, San Jose, CA, USA). Cells were harvested at 4 h (G 1 phase) and at 5 h (S phase) based on the results of the monitoring.
Phosphatase treatment of the immunoprecipitates
Nocodazole-treated M phase HeLa cells were prepared and divided into three parts. One and the other two parts were extracted with cell extraction buer (25 mM HEPES, pH 7.4, 0.5% Triton X-100, 1 mM EDTA, 150 mM NaCl, 1 mM MgCl 2 , 10% glycerol, 1 mM PMSF, 2 mg/ml aprotinin, 2 mg/ml leupeptin and 2 mg/ml pepstatin A) in the absence and presence of phosphatase inhibitors (2.5 mM Na 3 VO 4 , 50 mM NaF, and 100 mM b-glycerophosphate), respectively. Immunoprecipitation was done individually from these cell lysates by anti-kpm Ab and protein G sepharose FF as described above. The sample without phosphatase inhibitors and one of the two samples with phosphatase inhibitors were incubated with 2 units of shrimp alkaline phosphatase (USB Corporation, Cleveland, OH, USA) for 2 h at 378C. These samples together with the one undergoing no phosphatase treatment were subjected to SDS ± PAGE and subsequent Western blotting using anti-kpm Ab.
Cell cycle anaysis of kpm-transfected cells
HEK293T cells and HeLa cells were cotransfected with pEGFP-C3 (Clontech), a green¯uorescence protein (GFP) expression vector, and either pME18S (mock), pME-kpm, or pME-kpmK697A by the calcium phosphate method or with Eectene (Qiagen). After 2 days of culture, cells were harvested, ®xed with 2% formaldehyde, treated with 1 mg/ ml ribonuclease A, and stained with propidium iodide for cell cycle anaysis. The DNA content in GFP + cells was analysed by¯ow cytometry using a FACScan and ModFit LT software (Becton-Dickinson).
Note added in proof
The nucleotide sequence(s) reported in this paper has been submitted to the GenBank/EMBL Data Bank with accession number(s) AF207547.
